Method for coating IL-6 antibody with magnetic beads for single-molecule fluorescence immunization

By activating and coupling carboxy magnetic beads of IL-6 antibodies and combining with ultrasonic treatment, the problem of carboxy magnetic bead aggregation is solved, the dispersion and coating efficiency of the magnetic beads are improved, and efficient single-molecule fluorescence immunoassay is achieved. , provides stable and efficient IL-6 antibody-coupled magnetic beads.

CN119086897AInactive Publication Date: 2024-12-06上海邦先医疗科技有限公司
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411238994.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-05
Publication Date
2024-12-06
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In single-molecular fluorescence immunity technology, the aggregation of carboxylic magnetic beads leads to low efficiency in the coating process, and the existing dispersion methods are only suitable for small amounts of antibodies, which are difficult to meet the reagent requirements of single-molecular fluorescence immunity.

Method used

By activating carboxylic magnetic beads and coupling them with IL-6 antibodies, blocking treatment with blocking agents, and processing with ultrasonic cell disruptors, including steps such as activation, washing, coupling, blocking, dispersing and resuspending and preservation of magnetic beads. Optimize reaction conditions and particle size to improve the dispersion and uniformity of the magnetic beads.

Benefits of technology

Effectively improve the dispersion and coating efficiency of magnetic beads, ensure the stability and reliability of IL-6 antibody-coupled magnetic beads, improve the sensitivity and specificity of detection, and provide excellent performance IL-6 antibody coupling. Magnetic beads, suitable for single-molecular fluorescence immunoassay.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119086897A_ABST
    Figure CN119086897A_ABST
Patent Text Reader

Abstract

The invention provides a method for coating an IL-6 antibody with a magnetic bead for single-molecule fluorescence immunization, relates to the technical field of magnetic bead labeled antibodies, can effectively activate carboxyl magnetic beads, realizes efficient coupling of the IL-6 antibody and the magnetic beads, improves the coating efficiency and accuracy, and improves the coating efficiency and accuracy through a specific pretreatment solution, reaction conditions and an activation mode. The stability and the reliability of magnetic bead coating are guaranteed, the repeatability and the consistency of subsequent detection are facilitated, carboxyl magnetic beads with specific particle sizes are adopted, the reaction process is optimized, the coating effect is further improved, an ultrasonic cell crusher is utilized for treatment, the dispersity and the uniformity of the magnetic beads are improved, and the stability and the reliability of the magnetic bead coating are improved. The method is simple in process and easy to operate, the IL-6 antibody coupled magnetic beads with excellent performance can be obtained, powerful support is provided for single-molecule fluorescence immunoassay, and the method has wide application prospects and important practical significance in the fields of disease diagnosis, medical research and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of magnetic bead-labeled antibodies, and more specifically, particularly relates to a method for coating IL-6 antibodies with magnetic beads suitable for single-molecule fluorescent immunoassay. Background Art

[0002] The technology of magnetic bead-labeled antibodies is to couple antibodies to magnetic beads so that the coated antibodies can better bind to antigens. Antibodies are essentially proteins with many functional groups, such as amino-NH2, thiol, hydroxyl, carboxyl, etc. It is the spatial structure of proteins that allows magnetic beads to better bind to antibodies. Depending on the functional groups, the types of magnetic beads are naturally very diverse, including carboxyl magnetic beads, methyl methacrylate magnetic beads, and streptavidin magnetic beads. Among them, carboxyl magnetic beads are more commonly used in enzymatic chemiluminescence, while streptavidin magnetic beads are more commonly used in Roche electrochemiluminescence. Streptavidin magnetic beads are usually in the form of three components, biotin-labeled antibodies, magnetic beads, and luminescent labeled antibodies to form a kit, which has a milder reaction than other types.

[0003] Carboxyl magnetic beads are a type of biological magnetic beads. Magnetic beads generally have the characteristics of superparamagnetism, fast magnetic response speed, large specific surface area, monodispersity, colloidal stability, etc. The surface of carboxyl magnetic beads is modified with abundant carboxyl groups, which can couple proteins, nucleic acids, peptides, etc. to the surface of magnetic beads under the action of special chemical reagents. They are widely used in protein purification, immunoassay, molecular detection, NGS, cell separation and other fields.

[0004] In chemiluminescent immunoassay, magnetic beads are used as reaction carriers, on which specific antigens or antibodies are coated to capture target molecules in the analyte. Proteins can bind to carboxyl-modified particles through adsorption, which is mediated by hydrophobic and ionic interactions between proteins and the particle surface, and adsorption occurs very quickly. In addition to being adsorbed, proteins can also be covalently linked to the surface of carboxyl-modified particles. The carboxyl group can be activated by water-soluble carbodiimide and react with the free amino groups of the adsorbed protein to form an amide bond. There are mainly hydrophobic forces and covalent bonding. The commonly used buffer system in the coating process of carboxyl magnetic beads is the Tris system.

[0005] Aggregation may occur during the magnetic bead coating process. In this case, the magnetic bead and antibody coating process should be optimized.

[0006] At present, the chemiluminescence system is the most widely used carboxyl magnetic beads on the market. The so-called magnetic bead aggregation phenomenon in the antibody coating process is actually a large cluster aggregation visible to the naked eye. At this time, the magnetic beads have already undergone a large aggregation. However, most antibodies will basically have more than two magnetic beads combined during the magnetic bead coating process, which is generally invisible to the naked eye. If the magnetic beads before and after antibody coating are detected on a flow cytometer, a clear difference will be found.

[0007] Our single-molecule fluorescent immunoassay technique requires that the coated carboxyl magnetic beads be dispersed into a single state. The common dispersion method is to fully oscillate with a vortex oscillator or treat with a small ultrasonic cleaner. However, experiments have found that these two methods are very inefficient and are only suitable for a small amount of antibody-coated carboxyl magnetic beads.

[0008] Based on this, the present invention aims to design a method for coating IL-6 antibodies with magnetic beads suitable for single-molecule fluorescent immunoassay, thereby improving the dispersibility of the magnetic beads and meeting the reagent requirements for single-molecule fluorescent immunoassay. Summary of the invention

[0009] In order to solve the above technical problems, the present invention provides a method for coating IL-6 antibodies with magnetic beads suitable for single-molecule fluorescent immunoassay to solve the above problems.

[0010] A method for coating IL-6 antibody with magnetic beads for single-molecule fluorescent immunoassay, first activating carboxyl magnetic beads, then coupling IL-6 antibody to carboxyl magnetic beads to obtain IL-6 antibody-coupled magnetic beads, blocking with a blocking agent, and then treating with an ultrasonic cell disruptor, comprising the following steps:

[0011] S1: magnetic bead activation;

[0012] S2: washing of carboxyl magnetic beads;

[0013] S3: coupling;

[0014] S4: closed;

[0015] S5: magnetic bead dispersion;

[0016] S6: Resuspend and save.

[0017] Preferably, the IL-6 antibody is coupled to carboxyl magnetic beads to obtain IL-6 antibody coupled magnetic beads, wherein the pretreatment solution includes a sodium dodecyl sulfate solution.

[0018] Preferably, the particle size of the carboxyl magnetic beads is 3 μm.

[0019] Preferably, the carboxyl magnetic beads are mixed and activated with a mixture of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide before coupling with the IL-6 antibody, wherein the concentrations of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide are both 8-12 mg / L, the temperature is 22-28° C., and the time is 30 min.

[0020] Preferably, the activated carboxyl magnetic beads are washed 2 to 3 times in MEST buffer, wherein the concentration of MEST buffer is 50 mM and the pH is 5.0, and then the IL-6 antibody and the washed carboxyl magnetic beads are mixed and coupled at a temperature of 22 to 28° C. and a mixing and coupling time of 1 to 5 h.

[0021] Preferably, the coupled magnetic beads are placed in a MES buffer solution containing 0.1% glycine and 0.1% BSA for sealing treatment, wherein the sealing time is 5 to 8 hours and the sealing temperature is 22 to 28°C.

[0022] Preferably, the blocked carboxyl magnetic beads are placed in an ultrasonic cell disruptor for 2 minutes, maintained in a low temperature ice bath state, and the working coefficient is 1 second of work and 2 seconds of rest. The ultrasonically treated carboxyl magnetic beads are washed 2 to 3 times with Tris buffer, then resuspended in Tris buffer and stored at 2 to 8°C to obtain IL-6 antibody-coupled magnetic beads.

[0023] Preferably, the mass ratio of the IL-6 antibody-coated carboxyl magnetic beads to the magnetic beads is 1:50 to 1:200.

[0024] Compared with the prior art, the present invention has the following beneficial effects:

[0025] In the present invention, the carboxyl magnetic beads can be effectively activated and the efficient coupling of IL-6 antibody and magnetic beads can be achieved, thereby improving the coating efficiency and accuracy.

[0026] In the present invention, the stability and reliability of magnetic bead coating are ensured by using a specific pretreatment solution, reaction conditions and activation method, which is beneficial to the repeatability and consistency of subsequent detection.

[0027] In the present invention, carboxyl magnetic beads with a specific particle size are used to optimize the reaction process and further improve the coating effect.

[0028] In the present invention, the use of an ultrasonic cell disruptor for processing helps to improve the dispersibility and uniformity of the magnetic beads, thereby improving the sensitivity and specificity of the detection.

[0029] In the present invention, the method is simple in process, easy to operate, and can obtain IL-6 antibody-coupled magnetic beads with excellent performance, which provides strong support for single-molecule fluorescent immunoassay and has broad application prospects and important practical significance in the fields of disease diagnosis, medical research, etc. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 This is the display image after 2 minutes of vortex oscillation under a microscope in the present invention;

[0031] Figure 2This is the display image of the small ultrasonic cleaning instrument under the microscope of the present invention after 2 minutes of ultrasonication;

[0032] Figure 3 This is the display of the ultrasonic cell disruptor under a microscope after 2 minutes of ultrasonication in the present invention;

[0033] Figure 4 This is the display diagram of the flow cytometer of the present invention after vortexing for 2 minutes;

[0034] Figure 5 This is the display diagram after the small ultrasonic cleaning instrument under the flow cytometer of the present invention is ultrasonicated for 2 minutes;

[0035] Figure 6 This is the display diagram of the ultrasonic cell disruptor under the flow cytometer of the present invention after ultrasonication for 2 minutes;

[0036] Figure 7 It is a flow chart of the present invention. DETAILED DESCRIPTION

[0037] The following embodiments of the present invention are described in further detail in conjunction with the accompanying drawings and examples. The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.

[0038] See also Figure 1-7 The present invention provides a method for coating IL-6 antibody with magnetic beads for single-molecule fluorescent immunoassay, wherein the carboxyl magnetic beads are first activated, and then the IL-6 antibody is coupled to the carboxyl magnetic beads to obtain the IL-6 antibody coupled magnetic beads, which are blocked with a blocking agent, and then treated with an ultrasonic cell disruptor, comprising the following steps:

[0039] S1: Activation of magnetic beads; prepare a mixture of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS), wherein the concentrations of EDC and NHS are both 8-12 mg / L. Within this concentration range, EDC and NHS can fully exert their activation effects, and neither incomplete activation due to too low concentration nor unnecessary side reactions or adverse effects on the performance of magnetic beads due to too high concentration. Then, 3 μm carboxyl magnetic beads are added to the above mixture and mixed with a rotary mixer. The selection of 3 μm carboxyl magnetic beads has many advantages. This particle size is moderate. On the one hand, it can provide a more suitable specific surface area to ensure that there are enough reaction sites to bind to the IL-6 antibody. On the other hand, it will not cause problems such as difficult operation or easy agglomeration due to too small particle size. Mixing is carried out at a temperature of 22-28 ° C. This temperature range is close to room temperature, which is conducive to the smooth progress of the reaction and will not have a significant adverse effect on the activity of the magnetic beads and reagents. The mixing time is set to 30 minutes. After 30 minutes of sufficient mixing, the surface of the carboxyl magnetic beads can be fully activated, laying a solid foundation for the subsequent efficient coupling with the IL-6 antibody. During the activation process, EDC and NHS activate the carboxyl groups on the surface of the carboxyl magnetic beads through chemical reactions, making them easier to react with amino groups and other groups on the antibody. The appropriate temperature and time ensure that the activation reaction is fully carried out, while also avoiding adverse reactions or adverse effects on the performance of the magnetic beads that may be caused by improper conditions. At specific concentrations, EDC and NHS can effectively catalyze and promote the activation reaction, increase the rate and effect of the reaction, and ensure that the magnetic beads can play a better role in the subsequent coupling with the antibody;

[0040] S2: Washing of carboxyl magnetic beads; Wash the activated carboxyl magnetic beads of S1 with MEST buffer for 2 to 3 times. The concentration of MEST buffer is 50mM and the pH is 5.0. The concentration of 50mM can provide appropriate ionic strength and buffering capacity to maintain the stability of the reaction system. The pH of 5.0 provides a suitable acid-base environment, which helps to maintain the activity and stability of the magnetic beads. By washing, impurities such as unreacted activators can be removed, reducing interference with subsequent coupling reactions. The washing process is like a "purification" of the magnetic beads, removing unnecessary components that may interfere with subsequent reactions, so that the magnetic beads can participate in the coupling with IL-6 antibodies in a purer state. The washed magnetic beads can better play their role in subsequent reactions and improve the efficiency and quality of the coupling. At the same time, washing also helps to reduce the residual impurities, making the subsequent coupling of IL-6 antibodies and magnetic beads purer, thereby improving the quality of the product. The appropriate buffer and temperature range ensure that the coupling reaction can be carried out under appropriate conditions, improving the reaction efficiency and effect;

[0041] S3: Coupling; the washed carboxyl magnetic beads in S2 are added to the IL-6 antibody, and the mass ratio of the antibody and the magnetic beads of the IL-6 antibody coated carboxyl magnetic beads is 1:50 to 1:200. The selection of this mass ratio is of great significance. When the mass ratio is 1:50, it can ensure that a sufficient number of antibodies are bound to the magnetic beads to achieve a more adequate coating effect, while also avoiding the waste caused by excessive antibodies. When the mass ratio is 1:200, the cost is better controlled on the basis of ensuring full binding. Within this range, it can be flexibly adjusted according to actual needs and experimental conditions to achieve the best effect. Use a rotary mixer to mix, and the coupling time is 1 to 5 hours at a temperature of 22 to 28°C. Within this temperature range, the reaction can proceed relatively smoothly, and the reaction efficiency and product quality will not be affected by excessively high or low temperatures. The longer coupling time allows the antibody and magnetic beads to have enough time to fully bind, increasing the degree and stability of the coupling. During the coupling process, the amino groups on the antibody react chemically with the activated carboxyl groups on the surface of the magnetic beads to form a stable chemical bond, thereby achieving the coupling of the antibody and the magnetic beads. The presence of the buffer helps to keep the pH and other conditions of the reaction system relatively stable to avoid adverse changes that affect the reaction;

[0042] S4: Blocking; add the coupled carboxyl magnetic beads of S3 to MES buffer containing 0.1% glycine and 0.1% BSA for blocking treatment. The combination of 0.1% glycine and 0.1% BSA plays an important role in the blocking treatment. Glycine can bind to the unreacted active sites on the surface of the magnetic beads to reduce the possibility of nonspecific binding; BSA can further cover and block these sites to enhance the blocking effect. The blocking treatment time is 5 to 8 hours. During this longer period of time, it can ensure that the blocking reaction is fully carried out and further stabilize the binding of the antibody to the magnetic beads. The sealing temperature is 22 to 28°C. At this temperature, the blocking agent can play an effective role and is also conducive to maintaining the stability of the reaction system. By blocking the active sites on the surface of the magnetic beads that are not coupled to the antibody, the possibility of non-target substance binding in subsequent detection is reduced, thereby improving the specificity of the detection. Long-term blocking treatment helps to further stabilize the binding of the antibody to the magnetic beads and ensure its stability in subsequent applications. The appropriate temperature is conducive to the smooth progress of the blocking reaction, and the buffer maintains the stability of the system;

[0043] S5: Magnetic bead dispersion; Place the sealed carboxyl magnetic beads in an ultrasonic cell disruptor for 2 minutes, maintain a low-temperature ice bath state, and the working coefficient is 1s working and 2s rest. Ultrasonic treatment plays a key role in this process. The energy of ultrasound can evenly disperse the magnetic beads and avoid agglomeration. When the magnetic beads agglomerate, it may affect the subsequent processing and detection effects, and ultrasound can effectively break up these agglomerates, making the magnetic beads more evenly distributed in subsequent processing and storage, which is beneficial for subsequent use. During the ultrasonic process, the low-temperature ice bath state plays a protective role. Low temperature can reduce the impact on active ingredients such as antibodies and maintain their activity. After ultrasonic treatment, the dispersibility of the magnetic beads is significantly improved, providing a good foundation for subsequent washing and storage;

[0044] S6: Resuspend and store; the ultrasonically treated carboxyl magnetic beads are washed 2 to 3 times with Tris buffer, then resuspended and stored in Tris buffer at 2 to 8°C. Tris buffer provides a suitable environment for the magnetic beads, allowing them to exist stably. The washing process further removes possible residual impurities or substances that are not firmly bound, ensuring the purity and quality of the magnetic beads. Storage at a low temperature of 2 to 8°C is conducive to maintaining the performance of the magnetic beads and antibodies, and avoiding reduced activity or failure due to excessively high temperatures. The resuspended storage process allows the magnetic beads to be ready for subsequent testing or applications at any time, which is convenient and quick.

[0045] The IL-6 antibody is coupled to carboxyl magnetic beads to obtain IL-6 antibody coupled magnetic beads, wherein the pretreatment solution includes a sodium dodecyl sulfate solution, which is an aqueous solution of an anionic surfactant, and promotes the wetting and activation of the surface of the magnetic beads, is beneficial to the subsequent binding reaction of the antibody and the magnetic beads, helps to improve the interface properties of the reaction system, improves the reaction efficiency, enhances the coupling effect between the IL-6 antibody and the carboxyl magnetic beads, improves the success rate and stability of the coupling, makes the reaction more uniform and sufficient, reduces the occurrence of uncoupled or poor coupling, helps to improve the performance and quality of the IL-6 antibody coupled magnetic beads finally obtained, can help improve the solubility of certain components in the reaction system, ensures the smooth progress of the reaction, helps to improve the surface properties of the magnetic beads and antibodies, and promotes the coupling reaction between them.

[0046] The particle size of carboxyl magnetic beads is 3μm, which can provide a more suitable specific surface area, ensuring sufficient reaction sites for binding to IL-6 antibodies without causing problems such as difficulty in operation or agglomeration due to too small particle size. This particle size usually has good dispersibility, which is conducive to uniform distribution in the reaction system, ensuring the uniformity and consistency of the reaction, and achieving a good balance in magnetic responsiveness and reaction efficiency. It can be effectively controlled and can efficiently complete reactions such as antibody coating, which is conducive to obtaining better detection precision and accuracy in subsequent single-molecule fluorescent immunoassays.

[0047] Before coupling with IL-6 antibody, carboxyl magnetic beads were mixed and activated with a mixture of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide, wherein the concentrations of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide were both 8-12 mg / L, the temperature was 22-28°C, and the time was 30 min, so that the surface of carboxyl magnetic beads was fully activated, laying the foundation for the subsequent efficient coupling with IL-6 antibody, helping to form a more stable chemical bond connection, and ensuring the firmness of the combination of antibody and magnetic beads. 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) can activate the carboxyl groups on the surface of carboxyl magnetic beads, making them more likely to react with amino groups on antibodies. The appropriate temperature and time ensure that the activation reaction is fully carried out, while also avoiding adverse reactions or adverse effects on the performance of the magnetic beads that may be caused by improper conditions. At a specific concentration, EDC and NHS can effectively catalyze and promote the activation reaction, increase the reaction rate and effect, and ensure that the magnetic beads can play a better role in the subsequent coupling with antibodies.

[0048] The activated carboxyl magnetic beads were washed 2 to 3 times in MEST buffer, wherein the concentration of MEST buffer was 50 mM and the pH was 5.0. Then, the IL-6 antibody and the washed carboxyl magnetic beads were mixed and coupled at a temperature of 22 to 28 ° C. The mixed coupling time was 1 to 5 h. Unreacted activators and other impurities were removed by washing to reduce interference with subsequent coupling reactions. MEST buffer provided a suitable acid-base environment, which helped to maintain the stability of the reaction system. Washing reduced impurities, making the subsequent coupling of IL-6 antibody and magnetic beads purer and improving product quality. The appropriate buffer and temperature range ensured that the coupling reaction could be carried out under suitable conditions, improving the reaction efficiency and effect. The longer coupling time allowed the antibody and magnetic beads to have enough time to fully combine, increasing the degree and stability of coupling. The presence of the buffer helped to keep the pH and other conditions of the reaction system relatively stable to avoid adverse changes affecting the reaction.

[0049] The coupled magnetic beads were placed in a MES buffer containing 0.1% glycine and 0.1% BSA for sealing treatment, wherein the sealing time was 5 to 8 hours and the sealing temperature was 22 to 28°C to reduce nonspecific binding. By blocking the active sites on the surface of the magnetic beads that were not coupled to the antibody, the possibility of non-target substance binding in subsequent detection was reduced, thereby improving the specificity of the detection. Long-term blocking treatment helped to further stabilize the binding of the antibody and the magnetic beads and ensure its stability in subsequent applications. The appropriate temperature was conducive to the smooth progress of the blocking reaction. The buffer maintained the stability of the system. 0.1% glycine and 0.1% BSA worked together to better achieve the blocking of redundant sites and reduce interference factors on the test results.

[0050] The blocked carboxyl magnetic beads were placed in an ultrasonic cell disruptor for 2 minutes, maintained in a low-temperature ice bath state, and the working coefficient was 1s for work and 2s for rest. The ultrasonically treated carboxyl magnetic beads were washed 2 to 3 times with Tris buffer, and then resuspended and stored in Tris buffer at 2 to 8°C to obtain IL-6 antibody-coupled magnetic beads. Ultrasonic treatment helps to evenly disperse the magnetic beads and avoid agglomeration, so that the magnetic beads are more evenly distributed in subsequent processing and storage, which is conducive to subsequent use. Through ultrasound and washing, possible residual impurities or unbound substances are further removed. The low-temperature ice bath reduces the impact on active ingredients such as antibodies and maintains their activity. Washing and resuspending with Tris buffer provide a suitable storage environment for the magnetic beads, ensuring that the performance of the magnetic beads and antibodies can be better preserved at a specific temperature, which is convenient for subsequent use at any time.

[0051] The mass ratio of the antibody and the magnetic beads in the IL-6 antibody-coated carboxyl magnetic beads is 1:50-1:200, which ensures that there are enough magnetic beads to bind to the antibody and achieve a relatively sufficient coating effect. The appropriate ratio can achieve a good balance between the antibody and the magnetic beads, avoiding waste due to excessive antibodies and preventing problems such as insufficient binding or steric hindrance due to excessive magnetic beads, thereby improving the binding efficiency and helping to maintain the stable performance of the final product, so that it can play an ideal role in subsequent applications such as immunoassays. On the premise of meeting performance requirements, it can also control costs to a certain extent.

[0052] The IL-6 antibody-coupled magnetic beads obtained in the above example were diluted by the same multiple, observed under a microscope, and tested using a flow cytometer. The display graphs of each group of tests are as follows Figure 1 As shown, from Figure 1 It can be seen that after 2 minutes of vortex oscillation, multiple magnetic beads appeared to be clustered under the microscope, and the magnetic beads were not dispersed. The image displayed on the flow cytometer was divergent. After 2 minutes of ultrasonic cleaning with a small ultrasonic cleaner, the magnetic bead clustering phenomenon under the microscope improved, but some magnetic beads still gathered together and were not completely dispersed. The image displayed on the flow cytometer became compact, but still diverged. After 2 minutes of ultrasonication in the ultrasonic cell disruptor, there was basically no aggregation of magnetic beads under the microscope, the magnetic beads were in a single state, and the magnetic beads were basically completely dispersed. The image displayed on the flow cytometer was compact.

[0053] During the implementation of the entire method, each step is closely linked and coordinated with each other. From the activation of magnetic beads to coupling, to blocking, dispersion and resuspension, each link has been carefully designed and optimized to ensure that the final IL-6 antibody-coupled magnetic beads have good performance and quality. Through strict control and optimization of each step, the efficiency and success rate of the reaction can be improved, and errors and uncertainties can be reduced. At the same time, the detailed description and explanation also provide an important reference for subsequent experimental operations and optimization, which will help promote the further development and application of this technology.

[0054] In practical applications, this IL-6 antibody-coupled magnetic beads can be widely used in fields such as single-molecule fluorescent immunoassay. Its high sensitivity, high specificity and stability make it a very valuable detection tool. By continuously optimizing and improving this method, it is expected to further improve the performance of magnetic beads and the accuracy of detection, providing stronger support for fields such as biomedical research and clinical diagnosis. At the same time, the application of this method in other antibody or biomolecule-coated magnetic beads can also be further explored to expand its application scope and potential.

[0055] The present invention can effectively activate carboxyl magnetic beads and realize efficient coupling of IL-6 antibody and magnetic beads, improves coating efficiency and accuracy, ensures the stability and reliability of magnetic bead coating through specific pretreatment solution, reaction conditions and activation method, is beneficial to the repeatability and consistency of subsequent detection, adopts carboxyl magnetic beads with specific particle size, optimizes the reaction process, further improves the coating effect, and uses ultrasonic cell disruptor for processing, which helps to improve the dispersion and uniformity of magnetic beads, thereby improving the sensitivity and specificity of detection. The method has simple process, is easy to operate, and can obtain IL-6 antibody-coupled magnetic beads with excellent performance, provides strong support for single-molecule fluorescent immunoassay, and has broad application prospects and important practical significance in the fields of disease diagnosis, medical research, etc.

[0056] The embodiments of the present invention are given for the purpose of illustration and description, and are not intended to be exhaustive or to limit the invention to the disclosed forms. Many modifications and variations will be apparent to those of ordinary skill in the art. The embodiments are selected and described in order to better illustrate the principles and practical applications of the present invention and to enable those of ordinary skill in the art to understand the present invention and thereby design various embodiments with various modifications suitable for specific uses.

Claims

1. A method for coating IL-6 antibody with magnetic beads for single molecule fluorescent immunoassay, characterized in that: First, the carboxyl magnetic beads are activated, and then the IL-6 antibody is coupled to the carboxyl magnetic beads to obtain the IL-6 antibody coupled magnetic beads, which are blocked with a blocking agent and then treated with an ultrasonic cell disruptor. The following steps are involved: S1: magnetic bead activation; S2: washing of carboxyl magnetic beads; S3: coupling; S4: closed; S5: magnetic bead dispersion; S6: Resuspend and save.

2. A method for coating IL-6 antibody with magnetic beads for single molecule fluorescent immunoassay as claimed in claim 1, characterized in that: The IL-6 antibody is coupled to carboxyl magnetic beads to obtain IL-6 antibody coupled magnetic beads, wherein the pretreatment solution includes a sodium dodecyl sulfate solution.

3. A method for coating IL-6 antibody with magnetic beads for single molecule fluorescent immunoassay as claimed in claim 1, characterized in that: The particle size of carboxyl magnetic beads is 3 μm.

4. A method for coating IL-6 antibody with magnetic beads for single molecule fluorescent immunoassay as claimed in claim 1, characterized in that: Before coupling with the IL-6 antibody, the carboxyl magnetic beads were mixed and activated with a mixture of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide, wherein the concentrations of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide were both 8-12 mg / L, the temperature was 22-28° C., and the time was 30 min.

5. A method for coating IL-6 antibody with magnetic beads for single molecule fluorescent immunoassay as claimed in claim 1, characterized in that: The activated carboxyl magnetic beads were washed 2 to 3 times in MEST buffer, wherein the concentration of MEST buffer was 50 mM and the pH was 5.0, and then the IL-6 antibody and the washed carboxyl magnetic beads were mixed and coupled at a temperature of 22 to 28° C. for 1 to 5 hours.

6. A method for coating IL-6 antibody with magnetic beads for single molecule fluorescent immunoassay as claimed in claim 1, characterized in that: The coupled magnetic beads were placed in a MES buffer solution containing 0.1% glycine and 0.1% BSA for sealing, wherein the sealing time was 5 to 8 hours and the sealing temperature was 22 to 28°C.

7. A method for coating IL-6 antibody with magnetic beads for single molecule fluorescent immunoassay as claimed in claim 1, characterized in that: The blocked carboxyl magnetic beads were placed in an ultrasonic cell disruptor for 2 minutes, kept in an ice bath state, and the working coefficient was 1 second for work and 2 seconds for rest. The ultrasonically treated carboxyl magnetic beads were washed 2 to 3 times with Tris buffer, then resuspended in Tris buffer and stored at 2 to 8°C to obtain IL-6 antibody-coupled magnetic beads.

8. A method for coating IL-6 antibody with magnetic beads for single molecule fluorescent immunoassay as claimed in claim 1, characterized in that: The mass ratio of IL-6 antibody-coated carboxyl magnetic beads to magnetic beads is 1:50 to 1:200.

Citation Information

Patent Citations

  • Kit for detecting IL-6 and method for detecting IL-6

    CN111239414A

  • Method for coating magnetic beads with anti-phospholipid syndrome related protein and application of method

    CN115856307A